Dr. Madeline Mcneil Tarrillion, D.O. Dermatology Medicare: Medicare Enrolled Practice Location: 8060 Market St, Youngstown, OH 44512 Phone: 330-758-9189 Fax: 330-758-4487 |
Dr. Susan G Woods, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 20 Ohltown Rd, Youngstown, OH 44515 Phone: 330-884-1557 Fax: 330-799-0261 |
Sayeeda Ahsanuddin, Dermatology Medicare: Accepting Medicare Assignments Practice Location: 500 Gypsy Ln, Youngstown, OH 44504 Phone: 330-884-3573 |
Abby L Vrable, Dermatology Medicare: Accepting Medicare Assignments Practice Location: 8060 Market St, Youngstown, OH 44512 Phone: 330-758-9189 |
Dr. Chi Sown Ko, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 3132 Belmont Ave, Youngstown, OH 44505 Phone: 330-759-0644 Fax: 330-759-1893 |
Dr. Jenifer R Lloyd, D.O. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 8060 Market St, Youngstown, OH 44512 Phone: 330-758-9189 Fax: 330-758-4487 |
Anthony L Mehle, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 960 Windham Ct, Ste 2, Youngstown, OH 44512 Phone: 330-758-8866 Fax: 330-758-4051 |
News Archive
New data show ketamine (a drug widely used for anaesthesia and pain relief) has a rapid antidepressant effect in some patients with severe depression. The first UK study of ketamine intravenous infusions in people with treatment-resistant depression was conducted by the Oxford Health NHS Foundation Trust and the University of Oxford.
The majority of individuals involved with nine Canadian hospice volunteer programs are satisfied with their work, citing the appreciation and gratitude of patients and their families as the most satisfying aspect of volunteering, indicate study results.
The first trial to study patients with acute coronary syndrome who do not undergo coronary stenting or bypass surgery found no significant difference between two anti-clotting drugs - prasugrel and clopidogrel - in preventing the first occurrence of death, heart attack or stroke, according to Duke University Medical Center cardiologists.
Probi has signed a distribution and supply agreement with Sanofi. Following this the Consumer Healthcare division of Sanofi Korea is making a major launch of ProbiĀ“s gut health product, Probi Digestis starting in April 2014. Probi has already delivered products and received substantial orders for the coming quarters.
Recognizing that leukemia cannot be conquered with a "one-size-fits-all" approach, researchers are pursuing novel targeted therapies and combinations of existing treatment regimens with new agents for patient populations with historically poor prognoses, according to data presented today during the 56th American Society of Hematology Annual Meeting and Exposition.
› Verified 1 days ago